Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Summary

This is a trial in obese subjects to study the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of PF-05231023.

Timeline

Start

2013-09

Primary completion

2013-12

Completion

2013-12

Outcome

Outcome not reported

Stopped (Business): “The study was terminated on December 19th, 2013 due to a business decision by the Sponsor. No safety concerns have been observed in this study.”

Drugs

Indications